Your browser is old and is not supported. Upgrade for better security.

LEAH Labs

Curing Cancer in Dogs

Highlights

1
We’re developing the first cure for lymphoma in dogs.
2
We’ve killed cancer in a test tube with our therapeutic; a CAR-T cell specific for B cell lymphoma.
3
We use CRISPR to genetically engineer T cells, making them cancer fighting machines.
4
We're a team of world leading experts in gene editing, immunotherapy, and veterinary oncology.
5
CAR-T is the hottest area of cancer research today and is curing human patients with lymphoma.
6
The total market for our product is over $1.5B.
7
We've closed $163,000+ via Reg D since launching on Wefunder, and received a $35k non-dilutive grant on 1/31/2020.
8
We’re backed by Y Combinator. Other alumni include Ginkgo Bioworks, Atomwise, Science Exchange

Our Team

Chief Executive Officer
Genome hacker. Layla the mutt's dad. PhD in Molecular, Cellular, and Developmental Biology.

Dogs are part of the family and we don't feel that the current care they get is up to par; they deserve the same technological advances in healthcare that their humans get. Using our expertise in gene editing, we can bring innovation to the veterinary market that has never before been possible.

Chief Operations Officer
Biotech focused entrepreneur and genetic engineer! BA in Biology and Genetics.
Scientific Founder - Translational Medicine
Entrepreneur with 1 exit. Dean, Grad School of Biomed Sciences. PhD, Molecular Biology & Genetics.

Downloads

Overview